Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

In Vivo Validation of Alternative FDXR Transcripts in Human Blood in Response to Ionizing Radiation

L. Cruz-Garcia, G. O'Brien, B. Sipos, S. Mayes, A. Tichý, I. Sirák, M. Davídková, M. Marková, DJ. Turner, C. Badie

. 2020 ; 21 (21) : . [pub] 20201023

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011995

Grantová podpora
HPRU-CRTH-01 NIHR Newcastle Biomedical Research Centre

Following cell stress such as ionising radiation (IR) exposure, multiple cellular pathways are activated. We recently demonstrated that ferredoxin reductase (FDXR) has a remarkable IR-induced transcriptional responsiveness in blood. Here, we provided a first comprehensive FDXR variant profile following DNA damage. First, specific quantitative real-time polymerase chain reaction (qPCR) primers were designed to establish dose-responses for eight curated FDXR variants, all up-regulated after IR in a dose-dependent manner. The potential role of gender on the expression of these variants was tested, and neither the variants response to IR nor the background level of expression was profoundly affected; moreover, in vitro induction of inflammation temporarily counteracted IR response early after exposure. Importantly, transcriptional up-regulation of these variants was further confirmed in vivo in blood of radiotherapy patients. Full-length nanopore sequencing was performed to identify other FDXR variants and revealed the high responsiveness of FDXR-201 and FDXR-208. Moreover, FDXR-218 and FDXR-219 showed no detectable endogenous expression, but a clear detection after IR. Overall, we characterised 14 FDXR transcript variants and identified for the first time their response to DNA damage in vivo. Future studies are required to unravel the function of these splicing variants, but they already represent a new class of radiation exposure biomarkers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011995
003      
CZ-PrNML
005      
20210507102728.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21217851 $2 doi
035    __
$a (PubMed)33113898
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Cruz-Garcia, Lourdes $u Cancer Mechanisms and Biomarkers Group, Radiation Effects Department, Centre for Radiation, Chemical & Environmental Hazards, Public Health England, Chilton, Oxfordshire OX11 0RQ, UK
245    10
$a In Vivo Validation of Alternative FDXR Transcripts in Human Blood in Response to Ionizing Radiation / $c L. Cruz-Garcia, G. O'Brien, B. Sipos, S. Mayes, A. Tichý, I. Sirák, M. Davídková, M. Marková, DJ. Turner, C. Badie
520    9_
$a Following cell stress such as ionising radiation (IR) exposure, multiple cellular pathways are activated. We recently demonstrated that ferredoxin reductase (FDXR) has a remarkable IR-induced transcriptional responsiveness in blood. Here, we provided a first comprehensive FDXR variant profile following DNA damage. First, specific quantitative real-time polymerase chain reaction (qPCR) primers were designed to establish dose-responses for eight curated FDXR variants, all up-regulated after IR in a dose-dependent manner. The potential role of gender on the expression of these variants was tested, and neither the variants response to IR nor the background level of expression was profoundly affected; moreover, in vitro induction of inflammation temporarily counteracted IR response early after exposure. Importantly, transcriptional up-regulation of these variants was further confirmed in vivo in blood of radiotherapy patients. Full-length nanopore sequencing was performed to identify other FDXR variants and revealed the high responsiveness of FDXR-201 and FDXR-208. Moreover, FDXR-218 and FDXR-219 showed no detectable endogenous expression, but a clear detection after IR. Overall, we characterised 14 FDXR transcript variants and identified for the first time their response to DNA damage in vivo. Future studies are required to unravel the function of these splicing variants, but they already represent a new class of radiation exposure biomarkers.
650    _2
$a dospělí $7 D000328
650    _2
$a alternativní sestřih $7 D017398
650    _2
$a krev $x účinky záření $7 D001769
650    _2
$a poškození DNA $7 D004249
650    _2
$a vztah dávky záření a odpovědi $7 D004307
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory $x genetika $x radioterapie $7 D009369
650    _2
$a oxidoreduktasy $x genetika $7 D010088
650    _2
$a ionizující záření $7 D011839
650    12
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
700    1_
$a O'Brien, Grainne $u Cancer Mechanisms and Biomarkers Group, Radiation Effects Department, Centre for Radiation, Chemical & Environmental Hazards, Public Health England, Chilton, Oxfordshire OX11 0RQ, UK
700    1_
$a Sipos, Botond $u Oxford Nanopore Technologies, Gosling Building, Edmund Halley Way, Oxford OX4 4DQ, UK
700    1_
$a Mayes, Simon $u Oxford Nanopore Technologies, Gosling Building, Edmund Halley Way, Oxford OX4 4DQ, UK
700    1_
$a Tichý, Aleš $u Department of Radiobiology, Faculty of Military Health Sciences in Hradec Králové, University of Defence in Brno, 500 01 Hradec Králové, Czech Republic $u Biomedical Research Centre, Hradec Králové University Hospital, 500 01 Hradec Králové, Czech Republic
700    1_
$a Sirák, Igor $u Department of Oncology and Radiotherapy and 4th Department of Internal Medicine-Hematology, University Hospital, 500 05 Hradec Králové, Czech Republic
700    1_
$a Davídková, Marie $u Department of Radiation Dosimetry, Nuclear Physics Institute of the Czech Academy of Sciences, 180 00 Prague 8, Czech Republic
700    1_
$a Marková, Markéta $u Institute of Hematology and Blood Transfusion, 128 00 Praha 2, Czech Republic
700    1_
$a Turner, Daniel J $u Oxford Nanopore Technologies, Gosling Building, Edmund Halley Way, Oxford OX4 4DQ, UK
700    1_
$a Badie, Christophe $u Cancer Mechanisms and Biomarkers Group, Radiation Effects Department, Centre for Radiation, Chemical & Environmental Hazards, Public Health England, Chilton, Oxfordshire OX11 0RQ, UK
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 21 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33113898 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102727 $b ABA008
999    __
$a ok $b bmc $g 1650386 $s 1132374
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 21 $e 20201023 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a HPRU-CRTH-01 $p NIHR Newcastle Biomedical Research Centre
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace